Aortic stenosis (AS) and regurgitation (AR) may be treated with surgical aortic valve
replacement (SAVR), transcatheter AVR (TAVR), or medical therapy (MT). Data are lacking …

Background: The number of patients treated for aortic valve disease in the United States is
increasing rapidly. Transcatheter aortic valve replacement (TAVR) is supplanting surgical …

The 2020 American Heart Association/American College of Cardiology (AHA/ACC)
guidelines recommend surgical aortic valve replacement (SAVR) with a Class 1A …

Background The treatment of aortic stenosis is evolving rapidly. Pace of change in the care
of patients undergoing transcatheter aortic valve replacement (TAVR) and surgical aortic …

As the use of transcatheter aortic valve implantation (TAVI) expands to varying patient
populations, impacting the landscape of surgical aortic valve replacement (SAVR), this study …

We conducted a retrospective study using the NIS database from 2008 to 2018 to examine
the most contemporary national hospitalization trends of transcatheter (TAVR) and surgical …

Background Transcatheter aortic valve replacement (TAVR) is an alternative to surgical
aortic valve replacement (SAVR) for the treatment of aortic stenosis in patients at …

Aims To assess the contemporary trends in aortic stenosis (AS) interventions in the USA
before and after the introduction of transcatheter aortic valve implantation (TAVI). Methods …

On August 16, 2019, the US Food and Drug Administration (FDA) became the first regulatory
body worldwide to expand the indications for use of transcatheter aortic valve replacement …

Objectives: The purpose of this study was to investigate changes in the use of transcatheter
aortic valve replacement (TAVR) relative to surgical aortic valve replacement (SAVR) and to …